UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 162 filers reported holding UNIQURE NV in Q3 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $198,000 | -5.3% | 4,400 | 0.0% | 0.00% | – |
| Q1 2020 | $209,000 | -11.4% | 4,400 | +33.3% | 0.00% | – |
| Q4 2019 | $236,000 | +81.5% | 3,300 | 0.0% | 0.00% | – |
| Q3 2019 | $130,000 | +49.4% | 3,300 | +37.5% | 0.00% | – |
| Q3 2018 | $87,000 | -4.4% | 2,400 | 0.0% | 0.00% | – |
| Q2 2018 | $91,000 | +62.5% | 2,400 | 0.0% | 0.00% | – |
| Q1 2018 | $56,000 | +24.4% | 2,400 | +4.3% | 0.00% | – |
| Q4 2017 | $45,000 | – | 2,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |